Tool Helps Clinicians Determine When Tests Are Needed for Chest Pain
An online tool can accurately predict which patients with chest pain are likely to have normal non-invasive test results and remain free of cardiac adverse events.
Angina
Cardiovascular Angiogenic Gene Therapy Gets Fast Track Status
Angionetics has announced that its Phase 3 clinical investigation of Generx (Ad5FGF-4) has been granted Fast Track status by the Food and Drug Administration (FDA).
Angina Med Mix-up Leads to Recall
One lot of Actavis’ Nifedipine 10mg capsules is being recalled after a pharmacist reported finding a Procardia capsule in the bottle.
For Chronic Angina Patients, Depression May Negatively Impact Clinical Outcomes
Development of depression post-diagnosis tied to increased morbidity, mortality
Risks, Benefits of Cangrelor Examined in Angina, ACS
Consistent reduction in composite of death, MI, ischemia-driven revascularization, stent thrombosis
GoNitro Sublingual Powder Now Available
Espero announced the launch of GoNitro (nitroglycerin) sublingual powder for acute relief of an attack or prophylaxis of angina pectoris due to coronary artery disease.
FDA Approves Yosprala for Secondary CV Prevention with GI Protection
Aralez announced that the Food and Drug Administration (FDA) has approved Yosprala (omeprazole and aspirin) to treat patients who require aspirin for secondary prevention of cardiovascular (CV) and cerebrovascular events and who are at risk of developing aspirin-associated gastric ulcers.
Dr. Reddy’s Generic Nitrostat Launched
Dr. Reddy’s announced the launch of Nitroglycerin sublingual tablets, the generic version of Pfizer’s Nitrostat.
GoNitro Sublingual Powder Approved for Angina
Espero announced that the Food and Drug Administration (FDA) has approved GoNitro (nitroglycerin) sublingual powder for acute relief of an attack or prophylaxis of angina pectoris due to coronary artery disease.
Intermediate Dosage Strengths of Generic Lopressor Tabs Now Available
Mylan announced the launch of Metoprolol Tartrate Tablets in new 37.5mg and 75mg strengths, the generic version of Novartis’ Lopressor.
